Tvardi Therapeutics TVRD
NASDAQ TVRD
$1.16 -0.08 (-6.05%)
As of: Oct 2, 2026 · 12:11 PM EDT

Tvardi Therapeutics (TVRD) Non-Current Deffered Revenue (2018 - 2019)

Updated

Tvardi Therapeutics (TVRD) recorded Non-Current Deffered Revenue of $6.09 million in Q2 2019, down 79.9% from $30.3 million a year earlier and down 36.4% from the prior quarter.

Analysis

Tvardi Therapeutics (TVRD) Non-Current Deffered Revenue (2018 - 2019) Analysis & Trends

At the end of FY2018, Tvardi Therapeutics reported Non-Current Deffered Revenue of $15.18 million.

  • Per Business Quant, the preceding three quarters came in at $9.57 million (Q1 2019), $15.18 million (Q4 2018) and $18.3 million (Q3 2018).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Tvardi Therapeutics 11.73 Mn 11.73 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2019 6.09 Mn
Mar 31, 2019 9.57 Mn
Dec 31, 2018 15.18 Mn
Sep 30, 2018 18.30 Mn
Jun 30, 2018 30.30 Mn
API Access

Tvardi Therapeutics Non-Current Deffered Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=TVRD&period=max&api_key=YOUR_API_KEY